Tower Research Capital (TRC)’s Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share BOXD.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,922
Closed 6640
2023
Q1
$0 Hold
1,922
﹤0.01% 6644
2022
Q4
$0 Hold
1,922
﹤0.01% 6708
2022
Q3
$0 Hold
1,922
﹤0.01% 6805
2022
Q2
$0 Hold
1,922
﹤0.01% 6854
2022
Q1
$2K Sell
1,922
-4
-0.2% -$4 ﹤0.01% 5681
2021
Q4
$2K Buy
+1,926
New +$1.75K ﹤0.01% 5728

Tower Research Capital (TRC)'s BOXD.WS Position: Q2 2023 in Review

Tower Research Capital (TRC) sold out of Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share (BOXD.WS) in Q2 2023, closing a stake of 1,922 shares.

Tower Research Capital (TRC) first reported a position in BOXD.WS in Q4 2021 and held it in 6 quarters. The position peaked at $2K in Q1 2022. 0 funds tracked by Wall St. Rank hold BOXD.WS as of Q2 2023.

  • Tower Research Capital (TRC) reported no remaining Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share position as of Q2 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,922 Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share shares in Q2 2023.
  • Tower Research Capital (TRC) first reported a position in Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share position peaked at $2K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Boxed, Inc. Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $11.50 per share as of Q2 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.